323 related articles for article (PubMed ID: 32006396)
41. Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA).
Tsutsumi T; Hirayama F; Uekama K; Arima H
J Control Release; 2007 Jun; 119(3):349-59. PubMed ID: 17477999
[TBL] [Abstract][Full Text] [Related]
42. Zwitterionic chitosan-polyamidoamine dendrimer complex nanoparticles as a pH-sensitive drug carrier.
Liu KC; Yeo Y
Mol Pharm; 2013 May; 10(5):1695-704. PubMed ID: 23510114
[TBL] [Abstract][Full Text] [Related]
43. Hyaluronic acid-modified redox-sensitive hybrid nanocomplex loading with siRNA for non-small-cell lung carcinoma therapy.
Chen D; Zhang P; Li M; Li C; Lu X; Sun Y; Sun K
Drug Deliv; 2022 Dec; 29(1):574-587. PubMed ID: 35156491
[TBL] [Abstract][Full Text] [Related]
44. Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.
Tambe V; Thakkar S; Raval N; Sharma D; Kalia K; Tekade RK
Curr Pharm Des; 2017; 23(20):2952-2975. PubMed ID: 28292248
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid.
Madaan K; Lather V; Pandita D
Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of Amino-Functional Polyester Dendrimers Based on Bis-MPA as Nonviral Vectors for siRNA Delivery.
Stenström P; Manzanares D; Zhang Y; Ceña V; Malkoch M
Molecules; 2018 Aug; 23(8):. PubMed ID: 30110914
[TBL] [Abstract][Full Text] [Related]
47. A review of nanocarriers for the delivery of small interfering RNA.
Kesharwani P; Gajbhiye V; Jain NK
Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
[TBL] [Abstract][Full Text] [Related]
48. Preparation and evaluation of polyamidoamine dendrimer conjugate with glucuronylglucosyl-β-cyclodextrin (G3) as a novel carrier for siRNA.
Abdelwahab AF; Ohyama A; Higashi T; Motoyama K; Khaled KA; Sarhan HA; Hussein AK; Arima H
J Drug Target; 2014 Dec; 22(10):927-34. PubMed ID: 25148608
[TBL] [Abstract][Full Text] [Related]
49. Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells.
Ghaffari M; Dehghan G; Baradaran B; Zarebkohan A; Mansoori B; Soleymani J; Ezzati Nazhad Dolatabadi J; Hamblin MR
Colloids Surf B Biointerfaces; 2020 Apr; 188():110762. PubMed ID: 31911391
[TBL] [Abstract][Full Text] [Related]
50. A novel EGFR-targeted gene delivery system based on complexes self-assembled by EGF, DNA, and activated PAMAM dendrimers.
Yin Z; Liu N; Ma M; Wang L; Hao Y; Zhang X
Int J Nanomedicine; 2012; 7():4625-35. PubMed ID: 22942644
[TBL] [Abstract][Full Text] [Related]
51. Polyamidoamine (PAMAM) dendrimers modified with short oligopeptides for early endosomal escape and enhanced gene delivery.
Thuy le T; Mallick S; Choi JS
Int J Pharm; 2015 Aug; 492(1-2):233-43. PubMed ID: 26187169
[TBL] [Abstract][Full Text] [Related]
52. Promoting siRNA delivery via enhanced cellular uptake using an arginine-decorated amphiphilic dendrimer.
Liu X; Liu C; Zhou J; Chen C; Qu F; Rossi JJ; Rocchi P; Peng L
Nanoscale; 2015 Mar; 7(9):3867-75. PubMed ID: 25283447
[TBL] [Abstract][Full Text] [Related]
53. Efficient delivery of small interfering RNA into cancer cells using dodecylated dendrimers.
Chang H; Zhang Y; Li L; Cheng Y
J Mater Chem B; 2015 Nov; 3(41):8197-8202. PubMed ID: 32262877
[TBL] [Abstract][Full Text] [Related]
54. Ternary complex of plasmid DNA electrostatically assembled with polyamidoamine dendrimer and chondroitin sulfate for effective and secure gene delivery.
Imamura M; Kodama Y; Higuchi N; Kanda K; Nakagawa H; Muro T; Nakamura T; Kitahara T; Sasaki H
Biol Pharm Bull; 2014; 37(4):552-9. PubMed ID: 24694603
[TBL] [Abstract][Full Text] [Related]
55. [Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer].
Zhao WM; Xiu YC; Xu Y; Wang YM; Cheng ZK; Yu Q; Kong DL
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):575-9. PubMed ID: 18210874
[TBL] [Abstract][Full Text] [Related]
56. Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors.
Shan Y; Luo T; Peng C; Sheng R; Cao A; Cao X; Shen M; Guo R; Tomás H; Shi X
Biomaterials; 2012 Apr; 33(10):3025-35. PubMed ID: 22248990
[TBL] [Abstract][Full Text] [Related]
57. Polyamidoamine-Decorated Nanodiamonds as a Hybrid Gene Delivery Vector and siRNA Structural Characterization at the Charged Interfaces.
Lim DG; Rajasekaran N; Lee D; Kim NA; Jung HS; Hong S; Shin YK; Kang E; Jeong SH
ACS Appl Mater Interfaces; 2017 Sep; 9(37):31543-31556. PubMed ID: 28853284
[TBL] [Abstract][Full Text] [Related]
58. Comparison of cationic liposome and PAMAM dendrimer for delivery of anti-Plk1 siRNA in breast cancer treatment.
Bulbake U; Kommineni N; Ionov M; Bryszewska M; Khan W
Pharm Dev Technol; 2020 Jan; 25(1):9-19. PubMed ID: 30633621
[TBL] [Abstract][Full Text] [Related]
59. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
Akhtar S; Benter I
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
[TBL] [Abstract][Full Text] [Related]
60. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
Sato Y; Matsui H; Sato R; Harashima H
J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
